The National Blood Service of Latvia is a set of regional medical institutions and their structural units in Latvia that produce blood components and supply them to medical institutions. The paper characterises the procedures and ways of financing the institutions preparing blood and blood components -the The monographic and descriptive methods are used to study elements of problems and to synthesize interrelationships or formulate correlations. The inductive method was applied to make general conclusions from several facts or to determine correlations. The deductive method, in its turn, was used to logically systematise and theoretically explain empirical research results. The methods of analysis of balance sheet and financial indicators were applied to assess funding allocated to the organisations that are studied and its use efficiency. It was examined by a disperse analysis whether the funding allocated to preparing blood and blood components differs in various regions of Latvia.
Introduction
The National Blood Service of Latvia (hereinafter -the NBSL) is a set of regional medical institutions and their structural units in Latvia that produce blood components and supply them to medical institutions. The regional system of the NBSL includes the State Blood Donor Centre (hereinafter -the SBDC) with its affiliate in Rēzekne, the Blood Establishments of 9 hospitals (hereinafter -the BEs), the performance of which is stipulated by their agreements with the SBDC, and the Blood Offices of 32 hospitals (hereinafter -the BOs) in all the regions of Latvia that function as suppliers of blood and its components (SBDC, 2007) .
The basic function of the SBDC is to organise and coordinate the supply of blood components, which meet the quality standards, to medical institutions, therefore, government budget funds are allocated to the following activities:
• preparation of blood and its components;
• laboratory tests for blood of donors;
• quality control of blood components;
• immunity and haematological compatibility tests;
• administration of expenditure on the BEs of medical institutions; • purchase, storage, and dissemination of blood plasma;
• maintenance of the single information system of the NBSL; • blood gravity surgical services. Hierarchically, both the SBDC and companies (medical institutions which include the BEs and the BOs), in which the holder of share of capital stock is the Latvian Ministry of Health, are at the same level of subordination to the Ministry. Yet the SBDC Statute stipulates that the SBDC methodically manages, organises, and coordinates the production of blood components and supplies them to medical institutions on request, except the medical institutions having their own blood establishment (SBDC Statute, 2005) . Besides, the SBDC finances several costs related to blood preparation at the BEs. The research aim is to investigate and analyse the procedure of financing the institutions producing blood and its components that are included in the NBSL. The following research tasks are set forth to achieve the aim:
1. To investigate and analyse the procedure of financing the SBDC and the BEs; 2. To investigate and analyse the cash flow of the SBDC.
Research methods used:
The monographic and descriptive methods as well as analysis and synthesis are used to study elements of problems and to synthesize interrelationships or formulate correlations. The inductive method was applied to make general conclusions from several facts or to determine correlations. The deductive method, in its turn, was used to logically systematise and theoretically explain empirical research results. The methods of analysis of balance sheet and financial indicators were used to assess funding allocated to the organisations that are studied and its use efficiency. It was examined by a disperse analysis whether the funding allocated to preparing blood and blood components differs in various regions of Latvia.
Financing of the SBDC and its procedure
The SBDC is an institution directly subordinated to the Latvian Ministry of Health, the performance of which is financed from the government budget.
Any annual budget of the SBDC is set by a respective calendar year's Latvian law "On the Government Budget for the Year XX". Table 1 .
According to Table 1 , the amount of funding allocated to the SBDC from the government budget was volatile during the recent five years -from a 71.82% increase in 2007 compared to 2006 to a gradual reduction in the funding in 2009 and 2010. These sharp changes in budget funds do not allow rational and prudent investments in developing the infrastructure for testing, preparing, and storing blood and its components, as it is not possible to plan the amount of funds for a next year.
The indicators of asset turnover of the SBDC -asset turnover ratio (hereinafter -ATR), fixed asset turnover ratio (hereinafter -FATR), as well as current asset turnover ratio (hereinafter -CATR) in the period from 2005 to 2010 (see Table 2 ) show whether the funding allocated to the SBDC is efficiently used. The ATR shows how efficiently assets are used regarding net turnover, i.e. how many times a full cycle of production and turnover is done. Given the specifics of SBDC performance, one can consider that the SBDC performance is efficient, as its assets make a full cycle more than once a year. The performance efficiency is also determined by the amount of funding available to the SBDC. Since the SBDC produces blood and its components that are supplied to Latvia's medical institutions free of charge, the performance of the SBDC fully depends on the amount of funding allocated from the government budget. Its own revenues, which are laboratory tests for compensation, are relatively small.
Financing of the BEs and its procedure
Until 2006, the BEs of medical institutions were financed only from the funding allocated to these medical institutions. Such a system of financing was recognised as inefficient, as it could not provide adequate technological and medical conditions for producing blood in the entire NBSL. When making a decision on optimising the NBSL's structure and elaborating a conception for optimising the performance and structure of the National Blood Service of Latvia, the following factors as the main prerequisites for planning optimal locations of the NBSL in the country were examined: population density, locations of medical institutions in the country, availability of information technologies in accordance with the possibilities provided by the National Program's project "Establishment of a Single Information System for the National Blood Service of Latvia", and establishment of BEs in geographically advantageous locations in Latvian regions. As a result, by approving the optimisation of the NBSL's structure, a decision was made to retain 10 BEs instead of 8 with the same funding approved, which reduces the available funds of any BE to cover its maintenance costs by 20%.
The Conception envisaged allocating LVL 347840 to 8 BEs of the SBDC (BEs at Vidzeme Hospital, hospitals in the towns of Daugavpils, Jelgava, and Kuldīga, Liepāja Regional Hospital, Hospital No.1 in Rīga, Clinical University Hospital Gaiļezers, P.Stradiņš Clinical University Hospital) from the government budget to cover their maintenance costs. Yet by starting implementing an EU SF project "Establishment of a Single Information System for the National Blood Service of Latvia", it was decide to retain 10 BEs with the same funding (BE of Northern Kurzeme Regional Hospital located in Ventspils and the BE of Jēkabpils Regional Hospital).
Based on the amount of funding allocated to the SBDC, any BE spent LVL 3623.30 a month in 2006, including:
1. personnel cost -LVL 3350.43; 2. cost of premises, including electricity, heating, water/ sewage, waste removal, security, deratization, goods for cleaning -LVL 160.67; 3. transportation cost -LVL 112,20. With the economic situation improving in the country, and due to the fact that two additional BEs were included in the NBSL, the Latvian Ministry of Health made a decision to allocate additional LVL 193398 in 2007 to cover the costs of the BEs, thus raising the available funding to LVL 541238. Table 3 .
The SBDC changed the procedure of financing the BEs in 2010, differentiating the funding according to the quantity of blood produced. Besides, the BEs maintenance costs were differentiated after the State Audit Office of Latvia pointed to it for the second time.
As stipulated in the agreements between the SBDC and the BEs, medical institutions are covered the cost incurred due to preparing blood for the country's needs from the government budget every month, but not more than it is stipulated in the agreement's paragraph concerning maintenance cost that is computed individually for each BE since 2010. Based on an analysis of the SBDC, the maintenance cost that consists of salaries and state compulsory social insurance contributions, maintenance cost for premises, and transport cost is differentiated for each BE.
Given the blood production plan for a calendar year, the BEs are classified into 3 groups (see table 4):
• Large BEs -their blood production plan is from 1400 to 2000 litres a year (BE of P.Stradiņš Clinical University Hospital, Gaiļezers BE of Rīga Eastern Clinical University Hospital, and the BE of Daugavpils Regional Hospital).
• Medium BEs -their blood production plan is from 900 to 1000 litres a year (BEs of Vidzeme Hospital, Liepāja Regional Hospital, and Jelgava Hospital).
• Small BEs -their blood production plan is from 650 to 700 litres a year (BEs of Kuldīga Hospital, Northern Kurzeme Regional Hospital, and Jēkabpils Central Hospital Any group of personnel (doctors, junior personnel, paraprofessionals, and others) in each group of BEs has a certain number of employees:
• Large BEs -12 employees (2 doctors, 7 medical paraprofessionals, 2 junior medical employees, and 1 -others).
• Medium BEs -7 employees (1 doctor, 4 medical paraprofessionals, 1 junior medical employee 1 -others).
• Small BEs -6 employees (1 doctor, 3 medical paraprofessionals, 1 junior medical employee 1 -others). The SBDC computes the amount of salaries for any group of medical personnel in each group of BEs (it is not lower as stipulated by Paragraph 180 of the Cabinet's of Ministers 19 December 2006 Regulation No.1046 "Procedures of Organising and Financing Health Care") by multiplying an average monthly wage by an average number of employees in a personnel group (doctors, junior personnel, paraprofessionals, and others). The state compulsory social insurance contributions of personnel are also computed by this institution.
An average monthly expenditure on transport for a BE is obtained by summing up the respective expenditure of all the nine BEs for the previous calendar year and dividing by the number of BEs and the number of months a year.
An average monthly expenditure on maintenance of premises per BE is obtained as follows:
• average expenditure on maintenance of premises of a BE per square meter is computed, and the available monthly funding for covering maintenance cost is divided by the fl oor area of premises of all the nine BEs; • average expenditure on maintenance of premises per square meter is multiplied by the fl oor area of premises of each BE. Thus, the BEs are fi nanced from two sources -the SBDC's budget and the medical institution's budget. The medical institution covers the cost of its BE that is related to infrastructure (premises, equipment etc.), human resources, and other costs (administration of its BE etc.).
Since the funding of all the BEs was equal until 2010, a signifi cant difference is observed in the part of funding that is spent on preparing blood and its components. 
Source: developed by the authors according to information of the SBDC's Department of Planning and Economy
After analysing the percentage distribution of the BE funding during the period from 2006 to 2010 (see Table 5 ), the authors concluded that in general, the cost of preparing blood and its components accounts for only 20% of total cost, the other costs (approximately 80%) consist of expenditures on maintenance of a BE, which includes salaries, maintenance of premises, and transport. Respectively, the SBDC started a more rational use of the budget when made a decision on differentiating the funding for each BE; as a result, the total funding intended for the BEs was reduced by 10% or LVL 48711 since 2008.
The authors did a dispersion analysis to ascertain whether the funding allocated to producing blood and its components signifi cantly differ among the regions of Latvia. To assess the result gained, the signifi cance level was assumed α= 0.05.
When computing, it was found that the funding allocated to producing blood and its components do signifi cantly differ among the regions of Latvia (p = 0.0000086 < α = 0.05).
As of 1 March 2011, the funding is not individually allocated to the BEs and the BOs; they are fi nanced from each medical institution's budget that is also fi nanced from the national government budget. Besides, the BEs are also additionally fi nanced from the SBDC, the cooperation with which is stipulated in agreements. The agreements stipulate the amounts of blood to be produced and the coverage of costs incurred to produce donor blood in accordance with 
Cash fl ow of the SBDC
The NBSL's effi ciency is also characterised by a rational use of funds. Given the changes in the SBDC budget in the period 2005-2010 (see Table 1 ), the SBDC has to pay special attention to organising a rational and balanced fl ow of expenditure. Fig.1 presents the changes in the expenditure on maintenance of the SBDC during 2005-2010, which explicitly shows an increase and a decrease in the cash fl ow in the respective period. Salaries include also such items of expenditure as premium pay and bonuses (premium pay for night shifts, work under special conditions, etc.) as well as state social insurance contributions paid by employers, social benefi ts, and compensations. An increase in the expenditure on salaries can be explained by the overall economic situation in Latvia in 2007 and 2008 when wages sharply increased in the private sector, which promoted an increase in salaries in the public sector as well. After the crises began, salaries and the funding allocated for pay decreased, which is explicitly presented by the data for 2009 and 2010 in Fig.5 . It is forecasted that salaries will keep decreasing in 2011 as well, as the total SBDC budget for 2011 was reduced by additional LVL 3.5 million.
The increase in the expenditure on salaries was also determined by the extension of SBDC functions when the institution's structure was reformed and a gradual extension of its administrative and medical functions was started after implementing the conception for optimising this institution. As a result, the NBSL's staff (as well as amount of work) increased in both Rīga and Rēzekne. Such departments as the Department of Public Relations, the Department of Quality Management, and the Department of Labour Safety started operating, while the Departments of Accounting and Information Technology were extended.
The increase in expenditure took place not only due to an increase in salaries. As we can see in Fig.3 , prices rose for such items of expenditure as public utilities, administration of the SBDC, repairs, and the institution's maintenance.
The increase in the institution's expenditure on repairs and maintenance services can be explained by the depreciation of buildings and equipment. Since 2006 the SBDC invested LVL 166756 in the system's establishment from its own budget.
The increase in costs is determined also by an increase in tax payments paid by the SBDC as a government institution in the period 2005-2010 (see Fig.4 ). Other items of expenditure can be managed and impacted, whereas this item of expenditure can be hardly impacted, as the national tax system determines it. As we can see in Fig.4 , the largest increase in tax payments was observed during the recent years, besides, the annual tax payments continue increasing. Changes in the budget of the SBDC as the only medical institution in Latvia that performs various specifi c operations (for instance, preparation of cryoprecipitate, processing of blood components, apheresis operations for patients etc.) affect the quality and production of blood and its components. These changes affect the entire NBSL, as it not only partially fi nances the BEs, but also performs various tests on blood and its components that are not performed by the BEs.
To be stable and oriented towards long term development, it is important to the NBSL to plan and take into account its disposable funds, therefore, the health care policy of Latvia has to be based on stability. was implemented, the BEs were fi nanced from the government budget without the SBDC as a mediator. Such a model of fi nancing was regarded as ineffi cient, as it did not ensure equal -single safety, quality, technological and essential other -standards in blood production at all medical institutions in Latvia. 3. The amount of funding allocated to producing blood components signifi cantly differ among the regions of Latvia. 4. In fi nancing the BEs since 2010, the SBDC differentiates their funding according to the quantity of blood produced. At the same time, the agreements made between the SBDC and the BEs stipulate particular quantities of blood to be produced. It means that the output of blood at the BEs is limited, otherwise the medical institution to which a particular BE is subordinated has to pay for the excess quantity of blood. Taking into account the fact that a single system of distributing blood and its components exists in Latvia, such a model of fi nancing is ineffi cient, as it does not allow production of blood in towns where more blood donors are available.
5. After the NBSL optimisation conception was implemented, the extension of its functions affects expenditures of the SBDC.
